Quanterix Corporation (QTRX)
NASDAQ:QTRX
US Market

Quanterix (QTRX) Stock Price & Analysis

228 Followers

QTRX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$6.31 - $35.98
Previous Close$14.13
Volume115.55K
Average Volume (3M)343.57K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$343.74M
Total Debt (Recent Filing)$42.96M
Price to Earnings (P/E)-5.3
Beta0.48
Next EarningsMar 14, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-2.66
Shares Outstanding37,054,705
R-Squared0.17
Standard Deviation0.17
10 Day Avg. Volume371,526
30 Day Avg. Volume343,572
Price to Book (P/B)1.38
Price to Sales (P/S)6.67
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-9.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside2.36% Upside
Rating ConsensusHold
Alpha-0.00268
Number of Analyst Covering3


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

QTRX FAQ

What was Quanterix’s price range in the past 12 months?
Quanterix lowest stock price was $6.31 and its highest was $35.98 in the past 12 months.
    What is Quanterix’s market cap?
    Currently, no data Available
    When is Quanterix’s upcoming earnings report date?
    Quanterix’s upcoming earnings report date is Mar 14, 2023 which is in 39 days.
      How were Quanterix’s earnings last quarter?
      Quanterix released its earnings results on Nov 08, 2022. The company reported -$0.95 earnings per share for the quarter, missing the consensus estimate of -$0.439 by -$0.511.
        Is Quanterix overvalued?
        According to Wall Street analysts Quanterix’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Quanterix pay dividends?
          Quanterix does not currently pay dividends.
          What is Quanterix’s EPS estimate?
          Quanterix’s EPS estimate is -$0.47.
            How many shares outstanding does Quanterix have?
            Quanterix has 37,054,707 shares outstanding.
              What happened to Quanterix’s price movement after its last earnings report?
              Quanterix reported an EPS of -$0.95 in its last earnings report, missing expectations of -$0.439. Following the earnings report the stock price went up 1.286%.
                Which hedge fund is a major shareholder of Quanterix?
                Among the largest hedge funds holding Quanterix’s share is Gilder Gagnon Howe & Co LLC.. It holds Quanterix’s shares valued at 16M.

                  ---

                  Quanterix Stock Smart Score

                  5
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -50.74%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -23.70%
                  Trailing 12-Months
                  Asset Growth
                  -12.56%
                  Trailing 12-Months
                  The Quanterix stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Quanterix Corporation

                  Quanterix Corp. is a life sciences company, which develops ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its Single Molecule Array (Simoa) technology platform uses single molecule measurements to access previously undetectable proteins. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Lexington, MA.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  BioLife Solutions
                  BioNano Genomics
                  SomaLogic
                  Akoya Biosciences

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis